| Name | Title | Contact Details |
|---|
Arizona BioIndustry Association is a Phoenix, AZ-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Protech Home Medical is a rapidly growing leader in the provision of clinical respiratory equipment and service to patients.
Six in ten Americans live with at least one chronic condition, a leading driver of healthcare costs across the country. Medication non-adherence results in hundreds of billions in wasted costs annually and a higher mortality rate in the U.S. Pillo Health is tackling these issues head-on with an engaging and HIPAA-compliant technology platform dedicated to improving health outcomes for patients at home.
Assembly Biosciences (NASDAQ: ASMB) is a clinical-stage biotechnology company developing innovative therapeutics targeting hepatitis B virus (HBV) and diseases associated with the microbiome. The HBV program is focused on advancing a new class of potent, oral core inhibitors that have the potential to increase cure rates for chronically infected patients. The microbiome program is developing novel oral live microbial biotherapeutic candidates with Assembly`s fully integrated platform, including a robust process for strain identification and selection, GMP banking and production, and targeted delivery to the lower gastrointestinal tract with the GEMICEL® technology. We pride ourselves on creating a culture and work environment that is scientifically driven, ambitious, and collaborative. We encourage diversity of thought that leads to great innovation and are looking to add to our dynamic team great people who are driven to transform the lives of patients. We believe our Microbiome platform represents a best in class approach to developing biopharmaceutical agents from live biotherapeutic products. ABI-M201, our lead program in mildly to moderately active ulcerative colitis (UC), is currently in a phase 1b clinical trial. This program is part of a broader collaboration we established with Allergan in 2017 for gastrointestinal programs such as UC, Crohn`s disease and Irritable Bowel Syndromes with potential total development and commercial milestones of up to $2.8 billion. Our internal pipeline comprises first in class or best in class live microbial biotherapeutic approaches in areas such as oncology, immune mediated and metabolic disorders, and other areas of high medical need. Assembly is headquartered in Carmel, Indiana, while the R&D headquarters is in South San Francisco. The Company also has a microbiome manufacturing facility in Groton, CT, and offices in China.
NexgenRx is a Etobicoke, ON-based company in the Healthcare, Pharmaceuticals, & Biotech sector.